MDT

96.73

-0.29%↓

A

147.9

+0.78%↑

VEEV

223.62

-2.76%↓

HQY

85.81

+2.85%↑

NEOG

9.25

+1.43%↑

MDT

96.73

-0.29%↓

A

147.9

+0.78%↑

VEEV

223.62

-2.76%↓

HQY

85.81

+2.85%↑

NEOG

9.25

+1.43%↑

MDT

96.73

-0.29%↓

A

147.9

+0.78%↑

VEEV

223.62

-2.76%↓

HQY

85.81

+2.85%↑

NEOG

9.25

+1.43%↑

MDT

96.73

-0.29%↓

A

147.9

+0.78%↑

VEEV

223.62

-2.76%↓

HQY

85.81

+2.85%↑

NEOG

9.25

+1.43%↑

MDT

96.73

-0.29%↓

A

147.9

+0.78%↑

VEEV

223.62

-2.76%↓

HQY

85.81

+2.85%↑

NEOG

9.25

+1.43%↑

Search

Omnicell Inc

Abrir

SetorSaúde

50.61 0.52

Visão Geral

Variação de preço das ações

24h

Atual

Mín

50.3

Máximo

51.44

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

109.14

87.826

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+5.88% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

753M

2.2B

Abertura anterior

50.09

Fecho anterior

50.61

Sentimento de Notícias

By Acuity

7%

93%

5 / 361 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de jan. de 2026, 19:05 UTC

Grandes Movimentos do Mercado

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 de jan. de 2026, 23:41 UTC

Conversa de Mercado

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 de jan. de 2026, 23:41 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

13 de jan. de 2026, 23:33 UTC

Conversa de Mercado

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 de jan. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 de jan. de 2026, 23:10 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 de jan. de 2026, 23:03 UTC

Conversa de Mercado

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 de jan. de 2026, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 de jan. de 2026, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 de jan. de 2026, 21:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 de jan. de 2026, 20:39 UTC

Conversa de Mercado

Silver Settles at Another New High -- Market Talk

13 de jan. de 2026, 20:21 UTC

Conversa de Mercado

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 de jan. de 2026, 20:17 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 de jan. de 2026, 19:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 de jan. de 2026, 19:03 UTC

Ganhos

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 de jan. de 2026, 18:50 UTC

Ganhos

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 de jan. de 2026, 17:54 UTC

Conversa de Mercado

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 de jan. de 2026, 17:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Global Equities Roundup: Market Talk

13 de jan. de 2026, 17:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 de jan. de 2026, 17:49 UTC

Conversa de Mercado

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 de jan. de 2026, 17:38 UTC

Conversa de Mercado

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

13 de jan. de 2026, 17:19 UTC

Conversa de Mercado

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

5.88% parte superior

Previsão para 12 meses

Média 54.2 USD  5.88%

Máximo 63 USD

Mínimo 46 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

5 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat